Abstract
A three-dimensional model of the malarial drug target protein PfDXR was generated, and validated using structure-checking programs and protein docking studies. Structural and functional features unique to PfDXR were identified using the model and comparative sequence analyses with apicomplexan and non-apicomplexan DXR proteins. Furthermore, we have used the model to develop an efficient approach to screen for potential tool compounds for use in the rational design of novel DXR inhibitors.
Keywords: PfDXR, antimalarial, apicomplexan, inhibitors, fosmidomycin, binding affinity, IC50
Protein & Peptide Letters
Title: The Malarial Drug Target Plasmodium falciparum 1-Deoxy-D-Xylulose-5- Phosphate Reductoisomerase (PfDXR): Development of a 3-D Model for Identification of Novel, Structural and Functional Features and for Inhibitor Screening (Supplementary Information)
Volume: 17 Issue: 1
Author(s): Jessica L. Goble, Matthew R. Adendorff, Tjaart A.P. de Beer, Linda L. Stephens and Gregory L. Blatch
Affiliation:
Keywords: PfDXR, antimalarial, apicomplexan, inhibitors, fosmidomycin, binding affinity, IC50
Abstract: A three-dimensional model of the malarial drug target protein PfDXR was generated, and validated using structure-checking programs and protein docking studies. Structural and functional features unique to PfDXR were identified using the model and comparative sequence analyses with apicomplexan and non-apicomplexan DXR proteins. Furthermore, we have used the model to develop an efficient approach to screen for potential tool compounds for use in the rational design of novel DXR inhibitors.
Export Options
About this article
Cite this article as:
Goble L. Jessica, Adendorff R. Matthew, de Beer A.P. Tjaart, Stephens L. Linda and Blatch L. Gregory, The Malarial Drug Target Plasmodium falciparum 1-Deoxy-D-Xylulose-5- Phosphate Reductoisomerase (PfDXR): Development of a 3-D Model for Identification of Novel, Structural and Functional Features and for Inhibitor Screening (Supplementary Information), Protein & Peptide Letters 2010; 17 (1) . https://dx.doi.org/10.2174/092986610789909548
DOI https://dx.doi.org/10.2174/092986610789909548 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Genetics of the First Seven Proprotein Convertase Enzymes in Health and Disease
Current Genomics Severe Drug Hypersensitivity Reactions: Clinical Pattern, Diagnosis, Etiology and Therapeutic Options
Current Pharmaceutical Design Bio-Activities and Syntheses Developments of Triptolides
Mini-Reviews in Organic Chemistry A Summary of Electrospun Nanofibers as Drug Delivery System: Drugs Loaded and Biopolymers Used as Matrices
Current Drug Delivery Pharmacogenomics of Cardiovascular Complications in Diabetes and Obesity
Recent Patents on Biotechnology Respiratory Hypoxia and Oxidative Stress in the Brain. Is the Endogenous Erythropoietin an Antioxidant?
Current Chemical Biology Relationship Between Hypertension and Atherosclerosis: From a Viewpoint of the Most Potent Vasoconstrictor Human Urotensin II
Current Hypertension Reviews subject Index To Volume 9
Protein & Peptide Letters Winning a Won Game: Caffeine Panacea for Obesity Syndemic
Current Neuropharmacology Novel Targets for Antiinflammatory and Antiarthritic Agents
Current Pharmaceutical Design NK Cell Receptors and Their Interactions with MHC
Current Pharmaceutical Design Use of Novel m6A Regulator-mediated Methylation Modification Patterns in Distinct Tumor Microenvironment Profiles to Identify and Predict Glioma Prognosis and Progression, T-cell Dysfunction, and Clinical Response to ICI Immunotherapy
Current Pharmaceutical Design Developments and Scope of Space Food
Current Nutrition & Food Science Monoclonal Antibodies in Allergy; Updated Applications and Promising Trials
Recent Patents on Inflammation & Allergy Drug Discovery CDK5 and MAPT Gene Expression in Alzheimer's Disease Brain Samples
Current Alzheimer Research Progress in the Diagnosis and Treatment of Pulmonary Aspergillosis
Current Respiratory Medicine Reviews Statins in Aortic Disease
Current Pharmaceutical Design Dendritic Cells Modulate Iron Homeostasis and Inflammatory Abilities Following Quercetin Exposure
Current Pharmaceutical Design Matrix Metalloproteinases in Lung Diseases
Current Protein & Peptide Science Synthesis and Biological Evaluation of Some Hydrazone Derivatives as Anti-inflammatory Agents
Letters in Drug Design & Discovery